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Recently, the eﬀects of QT interval prolongation have received more attention among
clinicians, industry, and oﬃcial regulatory agencies. Some have advocated the total
elimination or discontinuing development of drugs which prolong the QT interval. In this
review, we will give a brief overview of the pathophysiology and the dynamic variability and
morphology of the QT interval. From the view point of arrhythmogenesis, QT interval
prolongation with increased heterogeneity of ventricular repolarization is critical. The
problem is how to detect such an abnormal repolarization. To detect heterogeneity, a new
index should be developed and validated, and it must incorporate QT variability and
morphology of the T wave. The heart rate correction of the QT interval is also an important
issue, and disclosing conﬂict-corrected QT intervals depend on the formulae used.
Not just QT interval prolongation is important; what also matters is the heterogeneity of
ventricular repolarization.
(J Arrhythmia 2007; 23: 210–222)
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1. Introduction
The Electrocardiogram (ECG) is still one of the
most important tools in the ﬁeld of cardiology,1) and
is described as the ‘‘cardiologist’s best friend.’’
Since Einthoven’s invention of modern electro-
cardiography2) (Figure 1), many types of equipment
have been developed and used clinically. Electronic
circuits for recording the ECG, however, are not
uniform among the numerous companies marketing
electrocardiographs, although there are certain rules
to assure the precision and accuracy for electro-
cardiographs. One rule speciﬁes that input signals
should be reconstructed with no more than a 5%
distortion.
From the view point of quality control and
standardization, however, little endorsement is given
to any electrocardiograph regarding precision and
accuracy of the recorded ECG, since the recording of
the ECG is not comparable among machines.
In the era of digital and global cooperation, data- or
information-sharing is extremely important, whether
the data are in analog or digital format. At present,
however, the system which enables mutual digital
data-sharing, such as digitally recorded ECGs by
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various machines, is not available. For this purpose,
new systems which make the mutual sharing of data
and information possible are still pending, including
sharing the data of other medical wave forms. In
other words, standardization of the ECG is necessary.
Recently, we developed the MFER3) (Medical
Waveform Format Encoding Rules; MFER commit-
tee http://www:mfer.org, http://www.medis.or.jp)
system, which enables us not only to view, but also
analyze, ECGs recorded by other digital machines
if the machines have MFER-adapted output. MFER
(ISO/TS11073–92001) was published very recently.
This system is applicable to standard 12-lead ECG
and ambulatory ECG monitoring systems. MFER is
now extending its application to electroencephalog-
raphy and other medical wave forms. Thus, MFER-
implemented electrocardiographs will be desirable
for future clinical studies, since it makes it would be
possible to compare and/or analyze all ECGs within
one center, or to share the data by with any center
which has a MFER. This is the ultimate goal of the
MFER committee.
2. QT Interval
2-1. Pathophysiology
Ventricular repolarization has long been one of
the major concerns of cardiologists since it holds
a very close relationship with the occurrence of
ventricular arrhythmias. Hence, the assessment of
VF/VT inducibility, eﬀective refractory period
(ERP), and other characteristics in patients with
severe ventricular arrhythmias have been performed
with invasive electrophysiological studies (EPS),
including the assessment of drug eﬀects. EPS is an
invasive examination and repetition may be diﬃcult.
Simple and cheap methods for evaluating ERP and/
or other electrophysiologic indices are still being
sought.
The QT interval has been assumed to be a
reﬂection of both ventricular depolarization and
repolarization, and it is nearly equal to the summa-
rized duration of action potential duration (APD) of
global right and left ventricular cardiomyocytes.
Thus, the QT interval has been assumed to be an
apparent surrogate of ERP which can be measured
on the ECG. Furthermore, the ECG is non-invasive,
cheap, and repeatable as well.
Bazett focused on the QT interval in his famous
paper published in 1920.4) At that time he had already
noticed that the QT intervals in various leads were
not the same and also that the QT interval between
males and females was not the same (i.e., gender
diﬀerences as well as its heart rate-dependence).
Since the ECG is a reﬂection of cardiac electrical
activity, it is important to understand ventricular
depolarization and repolarization from the view
point of electrical current ﬂow. The heart contains
many types of cells which are driven by electrical
signals. The electrical activity of each cell reveals
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Figure 1 The electrogram recorded by
Einthoven and its naming.
From ref. 2.
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distinct action potential conﬁgurations which char-
acterize cardiomyocytes from other excitable tissues,
namely, a long action potential and a refractory
period.
The list of variable cardiac electric currents,
exchangers, and others are shown in Figure 2.5,6)
The cardiac ventricular action potential duration is
inﬂuenced by variable conditions, such as electro-
lytes, autonomic nervous system transmitters, ische-
mia, peptides, hormones, and hypertrophy. The ionic
currents and exchangers ﬂow either inwardly or
outwardly, depending on their electrochemical gra-
dients.
Among all, the frequently involved ionic currents
are iKr, iKs, ito, iNa, and iCaL, regarding the QT
interval, since the action potential duration distinctly
depends on a minute balance of those outward and
inward currents, as illustrated in Figure 2. For
instance, a small increase of iKr in the plateau phase
does shorten the action potential duration (APD),
whilst the block of the same current by a certain drug
dramatically prolongs the APD according to the
degree of blockade and hence the QT interval,
known as acquired QT prolongation (reduction of
repolarization reserve).7–9) The inherited abnormality
regarding such ionic currents certainly results in an
abnormal QT interval and may be involved in the
arrhythmogenesis, which is described later. There-
fore, any genetic changes or synthesized compounds
which modify inward or outward currents, ions or
exchangers can modify the APD, resulting in QT
interval changes. There is a long-lasting list of drugs,
foods, and interventions with such actions.10–12)
From the clinical point of view, serum potassium
level is important since it can modify the ventricular
APD and the resting membrane potential. (Figure 3)
A prolonged QT interval and risk of sudden
cardiac death is known to be closely related in
populations of older adults.13–15)
2-2. Prolongation of the QT interval
Prolongation of the QT interval can be attributed
to the prolongation of ventricular APD, which is
due to either the increased inward currents or the
decreased outward currents.
The normal range of the QT interval is assumed
to be no more than 450ms in males and 460ms in
females.16) Thus a QT interval longer than 460ms
is usually assumed to be prolonged. The congenital
long QT syndrome is a well-known example.
Patients with congenital long QT syndrome (LQTS)
develop Torsades des Points (Tdp) that results in
sudden cardiac death during childhood or youth. Up
to now, 10 types of LQTS have been reported.17,18)
The details of LQTS can be found elsewhere.19–21)
Brieﬂy, the decrease in iKs and iKr with an increase
in iNa and iCa, has been identiﬁed to be due to
inherited abnormal gene expressions (Table 1).
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An acquired type of long QT syndrome is also
well-known.7,10) The most frequently encountered
acquired QT prolongation is attributed to the block of
iKr by variable agents, which eventually cause Tdp,
resulting in sudden cardiac death. Many drugs have
been withdrawn from the market due to such action
and/or propensity to induce Tdp, not only in Japan,
but also in other countries, although in some cases
inherent abnormal gene expression coexists.22–24)
However, in most cases, the victims of Tdp exhibited
a prolonged QT interval, usually accompanied by the
combination of iKr blocking agents with a low
potassium level and bradycardia.7,25)
It has been a priori assumed that the prolongation
of the QT interval is arrhythmogenic; there is little
information, however, regarding how much of the
prolongation is arrhythmogenic. So far few reports
have mentioned the distinct level of prolongation or
deﬁnite values of QT interval to be arrhythmogenic.
Joshi et al. analyzed 35 cases of Tdp.26) They
reported that at least a 25–30% prolongation of
the QT interval from baseline was noted in cases
of Tdp, and a mean nominal value of QT interval
increase in cases of Tdp was approximately 201ms
(48% increase; the absolute mean QT interval was
> 600ms in Tdp patients), whilst no Tdp developed
in patients who showed a QT interval < 500ms.
They also described that the QT prolongation and
ampliﬁcation of transmural dispersion of repolariza-
tion (TDR) was a powerful determinant of develop-
ing Tdp.26)
Previous reports27–30) have also suggested that the
association between a prolonged QT interval and
proarrhythmic risk may not be straightforward
by both clinical and experimental observations: 1)
diﬀerent drugs causing comparable absolute or
relative increases in repolarization do not always
result in similar Tdp incidences and 2) in serial
experiments using various doses of the same drug,
proarrhythmic outcome is not dependent on the
degree of the QT interval prolongation,
Calmodulin kinase II inhibitor can abolish both
EAD and DAD without changing the APD,31)
strongly suggesting that the interrelationship be-
tween the APD and arrhythmogenicity is not always
direct and not an unbreakable connection. These
arguments are all consistent with the notion that
the simple prolongation of the QT interval is not
necessarily arrhythmogenic, but the accompanied
Action potential from sheep cardiac Purkinje fiber in 2 potassium level
[K]0=4.0mEq
(K)0=5.4 4.0
[K]0=5.4 mEq
(Saikawa & Carmeliet unpublished observation)
Figure 3 An eﬀect of extracellular potas-
sium level on sheep cardiac Purkinje ﬁver.
Note the slight depolarization of resting mem-
brane potential and the marked shortening of
action potential duration.
Table 1 The list of gene abnormality.
 LQT 1: KCNQ1 (iKs)
 LQT 2: KCNH2 (iKr)
 LQT 3: SCN5A (iNa)
 LQT 4: ANK2 (Ankyrin 2)
 LQT 5: KCNE1 (iKs)
 LQT 6: KCNE2 (iKs)
 LQT 7: KCNJ2 (iK1)
 LQT 8: CACNA1C (iCaL)
 LQT 9: CAV3 (Caveolin 3)
 LQT 10: SCN4B (iNa)
Rearranged from reference 17 and 18
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increased heterogeneity of repolarization and/or the
exaggerated beat-to-beat variability of repolarization
is arrhythmogenic.32) Thus, it is not just a matter of
the QT interval prolongation, but a matter of the
heterogeneity of repolarization.
2-3. The shortening of the QT interval: The short
QT syndrome
The shortening of the QT interval is attributed to
the shortening of the APD due to an imbalance of
inward and outward electric current ﬂow.
The nominal range of a normal QT interval is
often described as < 450ms in males and 460ms in
females. However, this denotes only the upper limit
of the QT interval, without commenting on the lower
limit of the index.16) Thus, only the upper limit of the
index has been focused upon and discussed until
quite recently. Certainly, the lower limit of the QT
interval does exist and it may be around 350ms
according to Rautaharju et al.16) There has been no
active discussion on the lower limit of the QT
interval until now. Shortening of the QT interval,
however, has not usually been assumed to entail an
increased risk of arrhythmia.
The congenital long QT syndrome is a one
extreme side of a QT interval abnormality. The
recent report of sudden cardiac death associated with
a short QT interval33–35) opened the door to the other
side of extreme QT interval abnormality.
Gussak et al. reported an extremely short QT
interval in a 17-year-old Caucasian female patient
with a QT interval of 280ms at a heart rate of
69 bpm.33) They also reported a case of a 37-year-old
female with a very short QT interval who suddenly
died while waiting for an EPS. According to a
formula16) for prediction of the QT interval from a
patient’s heart rate, QTp (msec) = 656/(1 + heart
rate/100), all the patients in the Gussak et al. study
had a QT interval below 80% of the predicted value.
Further, the ECGs of the short QT interval patients
with associated ventricular arrhythmias showed tall,
peaked T waves and broad Tp-e intervals, suggesting
increased TDR.36) The syndrome also showed a high
incidence of supraventricular tachyarrhythmias, such
as atrial ﬁbrillation. Clearly there is a normal range
for the QT interval, with a lower and upper limit.
Like LQTS, SQT is now classiﬁed into 3 types
depending on their gene mutations: 1) SQT137)
(ERP < 150ms and VF inducible; KCNH2 (iKr)
mutation); SQT238) (ERP < 180ms and VF not
inducible; mutation in KCNQ1 [KvLQT1; iKs]);
and SQT339) (ERP 160ms and VF inducible;
mutation in KCNJ2 [iK1]). Thus it seems that it is
better if the value of the QT interval is between the
lower and upper extremities, which can be consid-
ered ‘‘a happy medium’’.
Up to now, no short QT syndrome patients have
been reported in Japan.
3. The Dynamics of the QT Interval
3-1. Heart rate correction of the QT interval
The QT interval is dependent on the heart rate.
The dependence has been analyzed since the days of
Bazett, and many formulae have been developed to
correct the QT interval to the heart rate. The oldest
one, Bazett’s formula, overcorrects when the heart
rate increases, as Simonson pointed out in 1962.40)
Since then, several formulae, such as the Frider-
icia,41) Framingham,42) and Hodges43) formulae, have
been developed and introduced. However, the oldest
one, the Bazett’s formula, is still in current use
according to some of the literature, including those
in the ﬁeld of cardiology. According to recent
publications, the Van de Water,44) Framingham,
and Hodges formulae are well-assessed and reveal
a rather good relation. Luo et al.45) analyzed human
ECGs from a database using four correcting for-
mulae. Consequently, the distribution of the QTc
showed the QTc corrected with Bazett’s formula
were distributed diﬀerently than the others, corrected
by Fridericia, Framingham, and Hodges formulae.
Milic et al.46) analyzed the eﬀects of beta2
agonist-induced QT prolongation and concluded that
using the Bazett formula may be misleading with
regard to the real eﬀects of QT prolongation by
various drugs. The magnitude of formula-dependent
diﬀerences of the QT interval may reach to 20–
30ms, which is rather signiﬁcantly large for the
requirements of ICH E14 and S7B.47)
Recently, the QT-RR relationship in a healthy
population has shown a substantial inter-subject
variability and high intra-subject stability. Batchvarov
et al.48) analyzed 12-lead 24-hour ECG recordings
which was repeated after 24 hours, 1 week, and 1
month in 75 healthy subjects. They compared intra-
subject stability with inter-subject variability and
concluded that the QT-RR interval relationship
showed substantial inter-subject variability, as well
as a high intra-subject stability. For example, the
slope of the linear QT-RR model (QT ¼ xRRþ )
in their study ranged from 0.137 to 0.199 in males
and 0.145 to 0.243 in females. On average, males
had an  of 0.163 and a  of 0.242, while in females
the  was 0.203 and the  was 0.225. The results
indicated that at a rate of 60/min, the QT interval
could vary between 62ms, which would be far
beyond measurement error.
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Malik et al.49) also reported similar results. They
showed that in a linear model (QTc ¼ QTþ  (1-
RR)),  ranged between 0.0928 to 0.2577, with a
mean of 0.1713. While in a parabolic model, like
QT ¼ QT=RR,  ranged between 0.233 and 0.485,
revealing the QT ranged between 379 and 401ms
at a rate of 75/min. At 85/min and 95/min, this
diﬀerence increased to 390–426msec and 401–450
msec, respectively. Thus, the choice of which QT
correction formula to use does inﬂuence the results
of the correction substantially.
Further, Smetana et al.50) analyzed the circadian
rhythm of the QT interval using diﬀerent heart rate
correction formulae of the QT interval. They used
ﬁve diﬀerent correction formulae, i.e., the Bazett,
Fridericia, Framingham, and Hodges, and an indi-
vidual formula derived from the individual QT-RR
relation. Interestingly, they found that the QTc
circadian rhythm disappeared by using the Bazett
formula, as shown in Figure 4A. We also analyzed
the circadian variation of the QT interval and noted
that although the QT interval revealed signiﬁcant
circadian rhythm, the QTc corrected by Bazett’s
formula did not show circadian variation.51) Thus,
the results were consistent with our results and from
the results of Smetana.50) They also concluded that
the inconsistency of the presence or absence of this
circadian variation of the QT interval might depend
on the methods used for heart rate correction.
The testimony of the above heart rate correction
formulae indicated that the individual formula dis-
closed the most heart rate independence, as shown in
Figure 4B. This means that averaging the QT correc-
tion with a certain formula is potentially hazardous
and might produce a false QT prolongation or
shortening. For developing new drugs, a much more
cautious measurement of the QT interval is neces-
sary. The QT-RR relation seems to have been
modulated in patients with congenital long QT
syndrome.52) The QT-RR relationship was also
modiﬁed in patients with a long QT syndrome with
an apparent normal QT interval, such as before and
after beta blockade treatment.53)
We analyzed the QT-RR relationship in 32
patients with sick sinus syndrome, i.e., those with
episodes of prolonged RR intervals (longer than 2.6
seconds).54) We classiﬁed the patients into two
groups: 1) no QT prolongation (< 0:44 sec) at a
heart rate of 60/min and 2) prolonged QT interval
(> 0:44 sec) at 60/min. They found that the slope of
the QT-RR relation was signiﬁcantly larger in those
with a prolonged QT at 60/min. The results meant
that patients with a prolonged QT revealed a larger
QT interval increase as the RR interval increased.
However, one should keep in mind that all these
data were collected by computer assistance, and little
veriﬁcation was performed by a QT specialist. There
is a choke point here for measuring correct and
precise QT interval. The golden standard here for the
measurements of the QT interval is the human eye.
Therefore the same critical issue remained as the
determination of the T wave end.
Taking all of these into consideration, the QT-RR
relationship was also modiﬁed by the underlying
pathophysiology, and we should be cautious when
assessing the QT interval from a variety of patients.
3-2. Dispersion of the QT interval: Four-dimen-
sional dispersion
3-2-1. Spatial dispersion
We may say that there are two types of dispersion,
spatial and temporal dispersion. The onset of the QT
interval and the oﬀset of the QT interval are rather
diﬃcult to recognize; however, apparently it seems
to disperse. The issue is whether the dispersion of the
QT onset and oﬀset really reﬂect a local dispersion
of heterogeneity of repolarization. The notion of
so-called QT dispersion proposed by the group of
Campbell,55,56) who passed away in 1998,57) has
invaded the electrocardiology ﬁeld and numerous
papers have been published, including ours.51,58,59)
This QT dispersion, however, has been controversial
in recent times. Assuming that the ECG is a
reﬂection of the cardiac vector loop to the respective
plane, the angle between the axis and vector loop
projection is critically important and may compro-
mise the T wave end identiﬁcation in certain
conditions. Namely, the projected loop may lap over
on the isoelectric baseline, which underestimates the
end of the T wave and then the QT interval. The end
of the T wave apparently seems to be dispersed.
However, this may simply be an artifact due to the
heterogeneous overlap of the ECG tracing on the
isoelectric baseline and may not be a surrogate
marker of ventricular repolarization heterogenei-
ty.60,61) Therefore, one has to measure the QT
interval from the earliest onset of the QRS complex
to the latest end of the T wave, which is the longest
QT interval.
Recent studies have emphasized the role of TDR;
the increase in the TDR is proarrhythmic and its
decrease is antiarrhythmic.36,62,63) TDR is proposed
by the group of Antzelevitch64) and is calculated as
the time interval between the peak of the T wave to
the end of the T wave, deduced from their wedge
preparation experiments. Many studies have been
done using this index as a surrogate of transmural
heterogeneity of repolarization. Further, a recent
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review36) described an increased TDR in patients
with cathecholaminergic ventricular tachycardia,
long QT, short QT, and Brugada syndrome. There-
fore, the TDR seems to be a promising index, a
seeming white knight, instead of QT dispersion.
Once again, we have to face, however, the issue of
measuring the end of the T wave. It might be better
to reserve TDR for the next step as an index of
heterogeneous repolarization through the ventricular
wall. The heterogeneity of repolarization does exist,
even physiologically due to heterogenous action
potential duration;65–67) however, the problem is its
detection method.
The QT dispersion still needs theoretical support
to justify that it reﬂects a local heterogeneity of
repolarization. TDR may also require theoretical
support.
3-2-2. Temporal dispersion
There is another type of dispersion or heteroge-
neity of repolarization and/or QT interval. The QT
interval is not ﬁxed, and may change as time goes
by owing to variable reasons, such as ischemia,
ﬁbrosis, and remodeling induced by variable cardi-
ovascular overload, as well as short-term endocrino-
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logic variation. Namely, the QT interval shows both
short-term and long-term variation. This line of
variation or heterogeneity is designated as temporal
dispersion.
One extreme pattern of temporal dispersion may
be a beat-to-beat variability of the QT interval.
Focusing on this beat-to-beat variability of the QT
interval, a novel index was invented.
Berger et al.68,69) hypothesized that abnormal beat-
to-beat changes exist in ventricular repolarization
and developed a novel algorithm for QT interval
assessment. They computed the heart rate mean
(HRm) and variance (HRv) and the QT interval mean
(QTm) and QT variance (QTv). A normalized QT
variability index was then calculated as follows:
QTVI (QT interval variability index) ¼ log10 fðQTv=
QTm2Þ=ðHRv=HRm2Þg The QTVI represents the log
ratio between the QT interval and heart rate varia-
bility, each normalized by the squared mean of the
respective time series. In patients with DCM, the
heart rate varied little and the QT interval ﬂuctuated
widely and unpredictably, while in control subjects,
the heart rate variability was large and the QT
variability was small. QT interval variability in-
creases with worsening functional NYHA class.
QT interval variability is a parameter of temporal
dispersion of repolarization and seems to be a marker
of increased risk of developing life-threatening
arrhythmias and sudden cardiac death. QT interval
variability is also associated with increased risk for
VT/VF in MADIT II patients.70,71)
Piccirillo et al.72) analyzed the long-term beta
blocker therapy on patients with chronic heart failure
secondary to ischemic cardiomyopathy in 130
patients. They randomized the patients into carvedi-
lol and metoprolol groups and investigated the
eﬀects of the drugs in head up tilt before and after
treatment. Both agents lowered the QT interval
variability and carvedilol seemed to improve the QT
interval variability index more than metoprolol.
Thus, the authors concluded that the QTVI may be
useful for stratifying patients at high risk for
ventricular tachycardia and ventricular ﬁbrillation.
Piccirrillo73) also reported that the QTVI is helpful
in stratifying the risk of sudden death in this
otherwise undertreated population in 396 patients
with chronic heart failure due to post-ischemic
cardiomyopathy, with an LVEF between 35 and
40% and in NYHA class I.
Thomsen et al.74,75) recently reported a new index
of beat-to-beat variability of repolarization (BVR)
using Poincare´ Plots in animal experiments. They
analyzed proarrhythmogenecity using left ventricular
monophasic action potential duration (LVMAPD)
and the QT interval with the analysis. They
concluded that beat-to-beat variability of LVMAPD
(beat-to-beat variability of ventricular repolarization
[BVR]) could predict the proarrhythmic action of
both cardiac and non-cardiac agents, but not that of
the QT interval. Thomsen et al. also described that
the canine group, which developed the increased
BVR, has a tendency to be proarrhythmic.76) Un-
fortunately, the usage of LVMAPD instead of the
QT interval is not applicable in a daily clinical
setting. Hence, if the QT interval is not available for
analysis, more sophisticated non-invasive parameters
may be necessary instead of the LVMAPD. Anyway,
the assessment of this beat-to-beat variability may
be promising to understand why certain arrhythmias
arise on some special occasions and why it did not
develop on other similar occasions.
4. The Morphology of the T Wave
The morphology of the T wave is also interesting.
The postextrasystolic potentiation of the U wave is
observed in patients with organic heart disease and
in those with congenital long QT syndrome. This
phenomenon is assumed to be associated with an
increased risk of an arrhythmic event.77) The U wave
designated here is not the same as the U wave which
is noted in healthy people. The U wave we deﬁne
here is the wave which encroaches to the descending
limb of the T wave and some may call a notch or a
hump on the T wave or T-U complex, while the U
wave, in the usual sense, is the wave which begins
after the T wave terminates and follows the return of
the T wave to the isoelectric baseline.
We previously reported seven cases of acquired
Tdp.78) In all 43 episodes from the 7 cases, the long-
short initiating cycle and R on T (U) phenomenon
were conﬁrmed in 42 among 43 Tdp episodes. The
QT interval just prior to the onset of Tdp was
increased as compared with the QT recorded 6–24
hours before. In most cases, the morphology of the T
wave changed and the notch (U) on the descending
limb of the T wave was seen (Figure 5A); further-
more, the amplitude of the U wave and U/T ratio
increased when U wave was followed by a PVB
and Tdp, resulting in an increased ratio of U/T,
irrespective of the underlying heart rate (Figure 5B).
We also analyzed the kinetics of the notch/U
wave in the idiopathic ventricular tachycardia (VT)
originating from the right ventricular outﬂow tract
(RVOT).79) The so-called RVOT-VT seems to share
a common characteristic, as above (Figure 5C).79)
In these patients, after the return of the T wave to
baseline, the U wave was seen. Interestingly, as the
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rate and the number of premature ventricular beats
(PVC) in the runs increased, the amplitude and
coupling interval of the U wave grew and encroach-
ed upon the descending limb of the preceding T
wave, and ﬁnally the two waves fused and formed
a notch, the so-called T-U complex or T1 and T2
wave.80) Frequently, the T2 wave becomes larger
than the T1 wave following runs of PVCs and
occasionally the PVC took oﬀ from the T2
wave,80,81) as shown in Figure 5C. The amplitude
of the T2 wave becames larger, even though the
diastolic interval increased. The mechanisms of
the augmentation of the T2 wave are interesting.
Apparently three diﬀerent mechanisms may be
possible: 1) early after-depolarization (EAD), 2)
delayed after-depolarization (DAD), and 3) mecha-
no-electrical feedback.82) Viskin et al.82) attributed
this ‘‘U’’ wave noted in such a condition to the last
candidate shown above, mechano-electrical feed-
back.
There is an interesting report83) describing an
acceleration-induced action potential prolongation
and EAD. They showed that the sudden acceleration
of the pacing cycle length from a range of 900 to
2,000ms to a range of 500 to 1,500ms induced
transient EAD activity and increased the EAD
amplitude in canine M cells. The acceleration usually
abrogates EAD and accompanies an abbreviation of
APD. Within discrete ranges of physiologic rates,
however, acceleration caused a transient prolonga-
tion of APD in 38% of the M cells. These character-
istics may also explain the behavior of the U wave
noted in the RVOT-VT reported in our paper.78)
Thus, as described in our paper, the possibility
remains that EAD is the cause of the ‘‘U’’ wave.
The T wave morphology is extremely important,
especially if adverse events occur under the admin-
istration of antiarrhythmic agents. Viskin et al. also
described an interesting T wave morphology change
in patients with acquired long QT syndrome.84) They
showed that variable changes in T wave morphology
depended on serum levels of potassium, adminis-
tered drugs, and other environmental inﬂuences.
Merri et al.85) tried to quantify the ECG changes
according to the 11 ECG indices. They analyzed
seven indices of ventricular repolarization charac-
teristics. Among them, Tm-To was designated as
‘‘late duration’’ and was independent from both
the heart rate and the QT interval and was one of
the independent indices of ventricular repolarization.
It is a strange but interesting coincidence that Tm
(T wave absolute maximum) - To (T wave oﬀset)
is a similar variable as subsequently proposed by
Antzelevitch et al.
5. Conclusion
Regarding the analysis of the QT interval, it is not
just a matter of the interval itself, but is also relates
to heterogeneity and abnormal T waveforms. We
cannot emphasize too strongly the importance of
analysis of this T wave morphology. We also need a
breakthrough for measurements of the QT interval
since the overlapping of the T wave end with the
isoelectric line is inevitable using the present
methods. The secular change in the position of heart
and body shape will also modify the vector loop,
and consequently the T wave end overlaps on the
isoelectric line and obscures the true end of the T
wave. At the same time, heart rate correction is also
important and the correction may mislead the results
in certain cases.
Regarding the QT interval, Japanese have the
saying, ‘‘For everything, to steer between two
extremities is important,’’ (Nanigotomo hodo-hodo
ga yoi. in Japanese). Taking the top or bottom value
will not always give us the right answer. However,
this statement is limited to the QT interval, and
cannot always be expanded to other areas.
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